SCHEMBL7348558

SCHEMBL7348558

CCOC(=O)CCNC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NCP(=O)(O)O

nearest known ligand 0.69

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MME P08473 3/20 0.48
ACE P12821 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.47
MMEL1 Q495T6 1/20 0.47
ECE1 P42892 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7312321 1.00 MME (0.48) MMEACEL3MBTL1MMEL1ECE1
SCHEMBL7354164 0.90 L3MBTL1 (0.46) L3MBTL1MMEL1
SCHEMBL7322563 0.90 HRH4 (0.50) MMEACEL3MBTL1MMEL1ECE1
SCHEMBL7322667 0.90 HRH4 (0.50) MMEACEL3MBTL1MMEL1ECE1
SCHEMBL7316905 0.88 L3MBTL1 (0.45) MMEACEL3MBTL1MMEL1ECE1
SCHEMBL7348239 0.88 L3MBTL1 (0.44) L3MBTL1MMEL1
SCHEMBL489232 0.86 MMEL1 (0.64) MMEACEMMEL1ECE1
SCHEMBL15202503 0.86 L3MBTL1 (0.63) MMEACEL3MBTL1MMEL1ECE1
SCHEMBL489231 0.86 MMEL1 (0.64) MMEACEMMEL1ECE1
SCHEMBL7319527 0.85 L3MBTL1 (0.42) L3MBTL1MMEL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0511940-A2 Phosphono/biaryl substituted dipeptide derivatives CIBA-GEIGY AG (CH) 1992-11-04 EP claimed
EP-0592367-A2 Phosphono/biaryl substituted dipeptide derivatives CIBA-GEIGY AG (CH) 1994-04-13 EP disclosed
US-5294632-A Diuretics and vasorelaxants CIBA-GEIGY CORPORATION (US) 1994-03-15 US disclosed
EP-0511940-A2 Phosphono/biaryl substituted dipeptide derivatives CIBA-GEIGY AG (CH) 1992-11-04 EP disclosed
US-5155100-A Treating cardiovascular disorders in mammals CIBA-GEIGY CORPORATION (US) 1992-10-13 US disclosed